Global Advanced Therapy Medicinal Products (ATMPs) Market Share

Statistics for the 2023 & 2024 Global Advanced Therapy Medicinal Products (ATMPs) market share, created by Mordor Intelligence™ Industry Reports. Global Advanced Therapy Medicinal Products (ATMPs) share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Global Advanced Therapy Medicinal Products (ATMPs) Industry

The Advanced Therapy Medicinal Products (ATMPs) market is currently fragmented in nature with the presence of several large to small- and medium-sized players. Some of the companies that are currently dominating the market are Novartis AG, Gilead Sciences Inc., JCR Pharmaceuticals Co. Ltd, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Bluebird Bio Inc., UniQure NV, Kolon TissueGene Inc., Vericel Corporation, and PHARMICELL Co. Ltd.

Advanced Therapy Medicinal Products Market Leaders

  1. Novartis AG

  2. Gilead Sciences, Inc.

  3. Bristol-Myers Squibb Company

  4. Bluebird Bio, Inc.

  5. Vericel Corporation

*Disclaimer: Major Players sorted in no particular order

Advanced Therapy Medicinal Products Market Concentration

Advanced Therapy Medicinal Products Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)